Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Extracellular yaluronidase from streptomyces koganeiensis

A hyaluronidase and hyaluronic acid technology, applied in the direction of enzymes, hydrolases, glycosylases, etc., can solve the problems of hyaluronidase difficulty, hyaluronidase instability, easy inactivation, etc.

Active Publication Date: 2012-05-02
FIDIA FARMACEUTICI SPA
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Production and purification of hyaluronidase from bacterial or animal origin is very difficult on an industrial scale, as hyaluronidase is unstable in aqueous solution and easily inactivated during purification

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Extracellular yaluronidase from streptomyces koganeiensis
  • Extracellular yaluronidase from streptomyces koganeiensis
  • Extracellular yaluronidase from streptomyces koganeiensis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Embodiment 1 (reference example)—according to U.S. Patent US 4,258,134 to Streptomyces Preparation, Purification and Characterization of KOGANEIENSIS Hyaluronidase

[0058] Streptomyces S. koganeiensis (31394 ATCC) was fermented according to the method described in "Materials and Methods". After centrifugation to obtain the supernatant, filter with a suitable cross-flow filter device, and then perform DEAE cellulose weak anion exchange column chromatography. Briefly, 1.2kg of DEAE cellulose was equilibrated with 25mM sodium phosphate buffer, pH 7.0, and then loaded into the column, and then the fermentation supernatant was dialyzed with the same buffer, and then loaded with 25mM NaCl containing 250mM , pH7.0 phosphate buffer for elution. After the chromatography, the components containing hyaluronidase activity were collected and enriched by ultrafiltration. After enrichment, they were dialyzed with 10 times the volume of acetate buffer (pH 5.0), and then CM-cellul...

Embodiment 2

[0061] Embodiment 2-according to the present invention Streptomyces KOGANEIENSIS hyaluronidase is prepared, Purification and Characterization

[0062] 2A) Preparation and purification

[0063] Sample Preparation

[0064] Streptomyces koganeiensis (ATCC 31394) was fermented and cultured according to the method described in "Materials and Methods", and the resulting clear supernatant (about 30 L) was ultrafiltered with a polyethersulfone filter membrane with a molecular weight cut-off of 10-kDa, and concentrated After 10 times, the hyaluronidase activity was measured. The concentrated supernatant was dialyzed with 10 times volume of 50 mM sodium acetate solution, pH 4.0, and then used in step a).

[0065] Step a) weak cation exchange column chromatography

[0066] The concentrated and dialyzed supernatant was loaded on a 200ml CM-Sepharose An XK-50 chromatography column (GE Healthcare) with Fast Flow resin (GE Healthcare) was equilibrated with 10 bed volumes (BV) of 50 ...

Embodiment 3

[0095] Embodiment 3-preparation of pharmaceutical dosage form

[0096] Dosage Form 1 - Hydrophilic Gel

[0097]

[0098] Methylparaben and propylparaben were dissolved in pure water at 80°C. After cooling the solution to room temperature, add hyaluronidase, shake until completely dissolved, then add polyethylene glycol 400, continue shaking until dissolved. will carbomer Add 974P to the above solution, continue to shake until it is evenly dispersed and fully hydrated, then add TEA to obtain an aqueous phase gel. Finally, glycerin and propylene glycol are added with shaking.

[0099] Dosage Form 2-Hydrophilic Cream (O / W Emulsion)

[0100] components

[0101] For the preparation of the oil phase, liquid paraffin, stearic acid and Tefose 1500 were shaken and melted at 50°C. In addition, for the preparation of the aqueous phase, an initial solution of methyl p-hydroxybenzoate at 80°C was used, then cooled to room temperature, glycerin and hyaluronidase were ad...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to Streptomyces koganeiensis ATCC 31394 hyaluronidase having molecular weight of 21.6 kDalton, which has hyaluronidase activity and stability markedly higher than those of the hyaluronidase obtained from such microorganism to date. The invention further relates to a process for the isolation and purification of said hyaluronidase and its use for the preparation of pharmaceutical compositions or as an analytical reagent.

Description

Background technique [0001] Hyaluronidases are hydrolases that cleave hyaluronic acid into D-glucuronic acid and N-acetylglucosamine in a variety of ways and also degrade acidic mucopolysaccharides of other connective tissues. For example, there are high concentrations of hyaluronidase in the culture supernatant of leech mouthparts, snake venom, bee venom, scorpion venom, and pathogenic bacteria such as pneumococcus, β-hemolytic streptococcus, and Staphylococcus aureus. In the human body, hyaluronidase exists in the cornea, ciliary body, spleen, skin and testis. In addition, sperm also have more hyaluronidase, which allows them to pass through the hyaluronic acid barrier that protects egg cells. [0002] Hyaluronidase is used medically in the treatment of edema, local inflammatory reactions, hemorrhoids and chilblains, and can facilitate the subcutaneous administration of certain active ingredients. It has also been reported that certain hyaluronidases do significantly reduc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/26C07K14/315
CPCC07K14/315A61K38/00C12N9/26C07K14/43595A61K38/47A61P29/00C07K14/36C12N9/2474C12Y302/01035G01N2333/924A61K39/35A61K45/06C12N9/2408
Inventor 卢西亚诺·墨西拿苏珊娜·瓦卡罗萨尔瓦托雷·卡鲁松乔瓦尼·热纳里
Owner FIDIA FARMACEUTICI SPA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com